ATC Group: A10BA02 Metformin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A10BA02 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A10 Drugs used in diabetes
3 A10B Blood glucose lowering drugs, excl. insulins
4 A10BA Biguanides
5 A10BA02 Metformin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 2 g

Active ingredients in A10BA02

Active Ingredient Description
Metformin

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.

Related product monographs

Title Information Source Document Type  
BROT Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
DIABETMIN Prolonged release tablet Marketing Authorisation Holder MPI, EU: SmPC
DIAFORMIN Film-coated tablet Pharmaceutical Benefits Scheme (AU) MPI, EU: SmPC
GLUCOPHAGE Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
GLUCOPHAGE Tablet / Extended-release tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
GLUMETZA Film coated tablet, extended release FDA, National Drug Code (US) MPI, US: SPL/PLR
GLYFORMIN Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
METFORAL Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
METFORMIN Oral Solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SIOFOR Prolonged-release tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Canada (CA)

Finland (FI)

France (FR)

Ireland (IE)

Japan (JP)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.